BST-2 was originally identified as a membrane protein in terminally differentiated human B cells of patients with multiple myeloma [28,29] BST-2 is a 30-36 kDa type II transmembrane protein, consisting of 180 amino acids [30]. This evidence concerns the gene BST2 and plasma cell myeloma.